SCHEMBL8546646

SCHEMBL8546646

C=C/C=C/c1cccc(C(F)(F)F)c1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 1/20 0.57
FBP1 P09467 1/20 0.54
P4HB P07237 2/20 0.48
MEN1 O00255 1/20 0.48
LMNA P02545 1/20 0.48
HSP90AA1 P07900 1/20 0.48
MAPT P10636 1/20 0.48
PKM P14618 1/20 0.48
KMT2A Q03164 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
MAOB P27338 5/20 0.46
PTGES2 Q9H7Z7 2/20 0.44
HTT P42858 1/20 0.43
THRB P10828 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAOA P21397 1/20 0.43
KDM4E B2RXH2 1/20 0.43
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8546648 1.00 NFE2L2 (0.57) NFE2L2FBP1P4HBMEN1LMNA
SCHEMBL31512684 0.81 FBP1 (0.58) NFE2L2FBP1P4HBMEN1LMNA
SCHEMBL13990553 0.81 NFE2L2 (0.62) NFE2L2FBP1P4HBMEN1LMNA
SCHEMBL366417 0.81 FBP1 (0.58) NFE2L2FBP1P4HBMEN1LMNA
SCHEMBL366416 0.81 FBP1 (0.58) NFE2L2FBP1P4HBMEN1LMNA
SCHEMBL28008101 0.81 FBP1 (0.58) NFE2L2FBP1P4HBMEN1LMNA
SCHEMBL3998676 0.81 NFE2L2 (0.61) NFE2L2FBP1P4HBMEN1LMNA
SCHEMBL1046285 0.81 NFE2L2 (0.61) NFE2L2FBP1P4HBMEN1LMNA
SCHEMBL1046286 0.81 NFE2L2 (0.61) NFE2L2FBP1P4HBMEN1LMNA
SCHEMBL216268 0.80 NFE2L2 (0.55) NFE2L2FBP1P4HBMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429595-B2 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents AVENTIS PHARMACEUTICALS INC. (US) 2008-09-30 US disclosed
EP-0690842-B1 4-ARYLISOINDOLE ANALGESICS ORTHO PHARMA CORP (US) 1998-12-16 EP disclosed
US-5508424-A REDUCED SIDE EFFECTS ORTHO PHARMACEUTICAL CORPORATION (US) 1996-04-16 US disclosed
EP-0690842-A1 4-ARYLISOINDOLE ANALGESICS ORTHO PHARMACEUTICAL CORPORATION (US) 1996-01-10 EP disclosed
WO-1994022823-A1 4-ARYLISOINDOLE ANALGESICS ORTHO PHARMACEUTICAL CORPORATION (US) 1994-10-13 WO disclosed